Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand

被引：14
|
作者：
Chetchotisakd, Ploenchan [1 ]
Anunnatsiri, Siriluck [1 ]
机构：
[1] Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen, Thailand
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2008年 / 49卷 / 02期
关键词：
D O I：
10.1097/QAI.0b013e31817cfdc9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1-Infected Patients
    Lanzafame, Massimiliano
    Lattuada, Emanuela
    Rigo, Fabio
    Vento, Sandro
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (02) : E81 - E82
  • [2] Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
    Ribera, Esteban
    Azuaje, Carlos
    Lopez, Rosa M.
    Domingo, Pere
    Curran, Adria
    Feijoo, Maria
    Pou, Leonor
    Sanchez, Paquita
    Sambeat, Maria Antonia
    Colomer, Joan
    Lopez-Colomes, Josep Lluis
    Crespo, Manuel
    Falco, Vicenc
    Ocana, Imma
    Pahissa, Albert
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 690 - 697
  • [3] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    HIV MEDICINE, 2011, 12 (09) : 570 - 579
  • [4] Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women:: Pharmacokinetics and efficacy
    López-Cortés, LF
    Ruiz-Valderas, R
    Pascual, R
    Rodriguez, M
    HIV CLINICAL TRIALS, 2003, 4 (03): : 227 - 229
  • [5] Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients
    Ford, Jennifer
    Boffito, Marta
    Maitland, Desmond
    Hill, Andrew
    Back, David
    Khoo, Saye
    Nelson, Mark
    Moyle, Graeme
    Gazzard, Brian
    Pozniak, Anton
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 1009 - 1016
  • [6] Once-daily atazanavir/ritonavir for HIV-associated lipodystrophy
    Reactions Weekly, 2008, 1216 (1) : 4 - 4
  • [7] Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz:: Pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy
    López-Cortés, LF
    Ruiz-Valderas, R
    Viciana, P
    Mata, R
    Gómez-Vera, J
    Alarcón, A
    Pachón, J
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (02) : 240 - 242
  • [8] Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients
    Mallolas, J
    Blanco, JL
    Sarasa, M
    Giner, V
    Martínez, E
    García-Viejo, MA
    Arnaiz, JA
    Cruceta, A
    Soy, D
    Tuset, M
    Soriano, A
    Codina, C
    Pumarola, T
    Carné, X
    Gatell, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) : 229 - 235
  • [9] Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients
    Pulido, Ildefonso
    Genebat, Miguel
    Alvarez-Rios, Ana I.
    De Pablo-Bernal, Rebeca S.
    Rafii-El-Idrissi Benhnia, Mohammed
    Pacheco, Yolanda M.
    Ruiz-Mateos, Ezequiel
    Leal, Manuel
    VIRAL IMMUNOLOGY, 2016, 29 (08) : 471 - 477
  • [10] Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
    van Heeswijk, RPG
    Veldkamp, AI
    Mulder, JW
    Meenhorst, PL
    Lange, JMA
    Beijnen, JH
    Hoetelmans, RMW
    AIDS, 2000, 14 (09) : F103 - F110
12345